Literature DB >> 15187303

c-Myc and epidermal stem cell fate determination.

Kimberly A Honeycutt1, Dennis R Roop.   

Abstract

The epidermis is sustained by a multipotent stem cell population that gives rise to cells of different fates including those forming hair follicles, interfollicular epidermis and associated glands such as sebaceous glands. The most intriguing evidence comes from using a variety of mouse models with which studies have found the WNT pathway to be involved in regulating stem cell fate decisions. These mouse models have been used to analyze different members of the WNT pathway in the epidermis and altogether suggest that different levels of beta-catenin correlate with the adoption of different epidermal stem cell fates. Recent data specifically analyzing c-Myc, a downstream target of the WNT pathway, has found that c-Myc can divert epidermal stem cells to a sebaceous gland fate at the expense of hair follicles. Also, newly emerging data using gene expression profiling techniques have uncovered a more direct role of c-Myc in stem cell fate determination.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15187303     DOI: 10.1111/j.1346-8138.2004.tb00687.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  15 in total

1.  Controversies in cancer stem cells: targeting embryonic signaling pathways.

Authors:  Naoko Takebe; S Percy Ivy
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

Review 2.  Stem cells for skin tissue engineering and wound healing.

Authors:  Ming Chen; Melissa Przyborowski; Francois Berthiaume
Journal:  Crit Rev Biomed Eng       Date:  2009

Review 3.  Epidermal stem cells: the cradle of epidermal determination, differentiation and wound healing.

Authors:  Maria I Morasso; Marjana Tomic-Canic
Journal:  Biol Cell       Date:  2005-03       Impact factor: 4.458

Review 4.  The contribution of epidermal stem cells to skin cancer.

Authors:  Michael J Gerdes; Stuart H Yuspa
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

5.  The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression.

Authors:  Xiao-Yong Zhang; Maya Varthi; Stephen M Sykes; Charles Phillips; Claude Warzecha; Wenting Zhu; Anastasia Wyce; Alan W Thorne; Shelley L Berger; Steven B McMahon
Journal:  Mol Cell       Date:  2008-01-18       Impact factor: 17.970

6.  Beta-catenin expression results in p53-independent DNA damage and oncogene-induced senescence in prelymphomagenic thymocytes in vivo.

Authors:  Mai Xu; Qing Yu; Ramesh Subrahmanyam; Michael J Difilippantonio; Thomas Ried; Jyoti Misra Sen
Journal:  Mol Cell Biol       Date:  2007-12-26       Impact factor: 4.272

Review 7.  The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness.

Authors:  Bin Bao; Asfar S Azmi; Shadan Ali; Aamir Ahmad; Yiwei Li; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Biochim Biophys Acta       Date:  2012-05-10

Review 8.  Mammary stem cells, self-renewal pathways, and carcinogenesis.

Authors:  Suling Liu; Gabriela Dontu; Max S Wicha
Journal:  Breast Cancer Res       Date:  2005-03-30       Impact factor: 6.466

9.  Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate.

Authors:  Howard Kendrick; Joseph L Regan; Fiona-Ann Magnay; Anita Grigoriadis; Costas Mitsopoulos; Marketa Zvelebil; Matthew J Smalley
Journal:  BMC Genomics       Date:  2008-12-08       Impact factor: 3.969

10.  Is stage-specific embryonic antigen 4 a marker for human ductal stem/progenitor cells?

Authors:  Ivka Afrikanova; Ayse Kayali; Ana Lopez; Alberto Hayek
Journal:  Biores Open Access       Date:  2012-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.